The following collection of State, Federal, and International regulation resources is provided to help educate citizens about the many regulatory issues impacting your health freedom rights. Use the tabs on the left to navigate the topics. This is not an all-inclusive list and please contact NHFC with further questions by email at:

NHFA promotes freedom of choice in health care such as:

  •  State Safe Harbor Exemption laws protecting access to health care practitioners;
  •  State Expanded Care Practice Acts protecting access to integrative health care professionals;
  •  Access to mercury free vaccines;
  •  Protection of personal and philosophical exemptions to state vaccine mandates;
  •  Protection of access to raw unpasteurized dairy and other farm products;
  •  Labeling of genetically modified foods;
  •  Support for organic farming and regenerative agriculture;
  •  Protection of parental rights to choose alternative health care for their children; and
  •  Supporting restriction of environmental toxins of all kinds.

Position Papers on Practitioner Laws Supported by NHFA

Position on Regulation of Specific Vocations and Professions Supported by NHFA

FDA Homeopathic Products:

NHFA to FDA, March 2018, Formal Comments in response to the FDA proposed Draft Guidance entitled: Drug Products Labeled as Homeopathic: Guidance for FDA Staff and Industry, Docket ID. FDA-2017-D-6580, Food and Drug Administration – Center for Drug Evaluation and Research (CDER) in cooperation with the Center for Biologics Evaluation and Research (CBER), December 2017.

CDC Communicable Disease:

NHFA to CDC, September, 2016, Formal Request for the Withdrawal of the CDC’s Notice of Proposed Rulemaking entitled: Control of Communicable Disease, Docket No. CDC-2016-0068, Department of Health and Human Services, Center for Disease Control and Prevention, August 2016.

FDA New Dietary Ingredients:

NHFA November 2011, Formal Comments in response to the FDA proposed Draft Guidance: “Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues; Availability”, Docket No. FDA–2011–D–0376 20, July 2011.

Creating New Laws:

Miller, D, 2009. Creating New Health Care Laws and Regulations, Alternative and Complementary Therapies.

Dietary Supplement Product Labeling:

Miller, D, 2007. Freedom of Speech and Truthful Information in Health Care, Alternative and Complementary Therapies.

CAM and the FDA:

NHFA to FDA, 2007, Formal Comments in response to the FDA proposed Draft Guidance entitled: “Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration” Docket ID. 2006d-0480, Department of Health and Human Services, Food and Drug Administration, December 2006